- Investing Ideas
- French Pharmaceuticals & Biotech Large Cap High Growth Potential
French Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
ABIVAX Société Anonyme
Market Cap: €9.6b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€102.30
7D
-0.6%
1Y
51.3%
Sartorius Stedim Biotech
Market Cap: €18.9b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€194.30
7D
7.6%
1Y
10.9%
Eurofins Scientific
Market Cap: €12.9b
Provides various analytical testing and laboratory services worldwide.
ERF
€74.08
7D
6.3%
1Y
13.0%